Focus:
Researchers from the Quantitative Biosciences Institute (QBI) Covid-19 Research Group (QCRG) at the University of California, San Francisco (UCSF) and their collaborators have identified 69 potential Covid-19 drug candidates and...
The Covid-19 pandemic raging across the globe has a multitude of implications across healthcare sectors and disease indications. The cardiovascular and metabolic disorder (CVMD) space is no exception, as Covid-19...
Coronavirus disease 2019 (Covid-19), declared a pandemic by the World Health Organization (WHO) on 11 March 2020, has now spread across 175 countries with approximately 480,000 total confirmed cases worldwide,...
Treatment options for COVID-19 are urgently needed as the total number of confirmed cases globally rises to 550,000 on Friday and the US becomes the country with the most confirmed...
Immune checkpoint inhibitors (ICIs) have led a shift away from mainstay cytotoxic agents and targeted therapies in the treatment of cancer, largely due to the unprecedented improvement in survival outcomes...
Recently, President Trump has noted the use of hydroxychloroquine and chloroquine as treatment options for patients with Covid-19 and subsequently ordered the FDA to grant approval on the grounds of...
Intarcia has received a second FDA rejection for its diabetic drug implant ITCA 650, a matchstick-like osmotic pump that is subcutaneously placed and continuously releases a six-month dose of exenatide....
Invasive Pneumococcal Disease (IPD) presents a significant public health concern globally. India leads the way with the highest number of diagnosed incident cases of IPD in the five major Asia-Pacific...
As the Covid-19 pandemic continues to spread globally, pharmaceutical companies are experiencing the shift towards working from home, which has various impacts on the industry, with the most notable one...
The number of confirmed cases of Covid-19 in the US is increasing at an average of 41% per day, which could be driven by a lack of consistent infection control...
